Tsz K. Fung, Ph.D.
Affiliations: | 2006 | Hong Kong University of Science and Technology, Clear Water Bay, Kowloon, Hong Kong |
Area:
Cell BiologyGoogle:
"Tsz Fung"Mean distance: (not calculated yet)
Parents
Sign in to add mentor| Randy Y. C. Poon | grad student | 2006 | HKUST | |
| (The functions and proteolysis of cyclin A and cyclin F during mitosis.) | ||||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Luo H, Zhu G, Xu J, et al. (2019) HOTTIP lncRNA Promotes Hematopoietic Stem Cell Self-Renewal Leading to AML-like Disease in Mice. Cancer Cell |
| Luo H, Zhu G, Fung TK, et al. (2019) Hottip Lncrna Reinforces CTCF Defined Chromatin Boundaries and Drives Wnt Target Gene Expression in AML Leukemogenesis Blood. 134: 277-277 |
| Fung TK, Zeisig B, Zarowiecki M, et al. (2019) Reconstruction of Human AML Reveals Stem Cell Origin and Therapeutic Targets for Treatment Resistant CD34-/Lo MLL-Rearranged Leukemia Blood. 134: 3203-3203 |
| Siriboonpiputtana T, Zeisig BB, Zarowiecki M, et al. (2017) Transcriptional memory of cells of origin overrides β-catenin requirement of MLL cancer stem cells. The Embo Journal |
| Cheung N, Fung TK, Zeisig BB, et al. (2016) Targeting Aberrant Epigenetic Networks Mediated by PRMT1 and KDM4C in Acute Myeloid Leukemia. Cancer Cell. 29: 32-48 |
| Esposito MT, Zhao L, Fung TK, et al. (2015) Synthetic lethal targeting of oncogenic transcription factors in acute leukemia by PARP inhibitors. Nature Medicine |
| Man CH, Fung TK, Wan H, et al. (2015) Suppression of SOX7 by DNA methylation and its tumor suppressor function in acute myeloid leukemia. Blood. 125: 3928-36 |
| Fung TK, So CWE. (2013) Overcoming treatment resistance in acute promyelocytic leukemia and beyond Oncotarget. 4: 1128-1129 |
| Fung TK, Gandillet A, So CW. (2012) Selective treatment of mixed-lineage leukemia leukemic stem cells through targeting glycogen synthase kinase 3 and the canonical Wnt/β-catenin pathway. Current Opinion in Hematology. 19: 280-6 |
| Man CH, Fung TK, Ho C, et al. (2012) Sorafenib treatment of FLT3-ITD(+) acute myeloid leukemia: favorable initial outcome and mechanisms of subsequent nonresponsiveness associated with the emergence of a D835 mutation. Blood. 119: 5133-43 |